63 related articles for article (PubMed ID: 483712)
1. [In vitro humeral serum cytotoxic reactions in melanoma].
Korosteleva TA; Veresova OV; Khachaturyan LM
Vopr Onkol; 1979; 25(9):12-4. PubMed ID: 483712
[TBL] [Abstract][Full Text] [Related]
2. [Humoral antitumor cytotoxins in patients with melanoma of the skin].
Korosteleva TA; Veresova OV; Khachaturian LM
Vopr Onkol; 1975; 21(5):61-3. PubMed ID: 1210146
[TBL] [Abstract][Full Text] [Related]
3. Clinical and immunological significance of human melanoma cytotoxic antibody.
Bodurtha AJ; Chee DO; Laucius JF; Mastrangelo MJ; Prehn RT
Cancer Res; 1975 Jan; 35(1):189-93. PubMed ID: 1109788
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor immunoreactivity in patients with malignant melanoma.
Nairn RC; Nind AP; Guli EP; Davies DJ; Little JH; Davis NC; Whitehead RH
Med J Aust; 1972 Feb; 1(9):397-403. PubMed ID: 4554232
[No Abstract] [Full Text] [Related]
5. Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.
Itoh K; Tilden AB; Balch CM
Cancer Res; 1986 Jun; 46(6):3011-7. PubMed ID: 3486040
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of the level of humoral cytotoxins and delayed hypersensitivity skin reactions with survival of patients with melanoma of the skin].
Korosteleva TA; Vagner RI; Veresova OV; Potapenkova LS
Vopr Onkol; 1983; 29(4):38-40. PubMed ID: 6858049
[TBL] [Abstract][Full Text] [Related]
7. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
[TBL] [Abstract][Full Text] [Related]
8. Antimelanoma immunity in vitiligo and melanoma patients.
Juranic ZD; Stanojevic-Bakic N; Zizak Z; Babovic N; Radovic-Kovacevic V; Stanojkovic T; Dzodic R
Neoplasma; 2003; 50(4):305-9. PubMed ID: 12937846
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response.
Mukherji B; Wilhelm SA; Guha A; Ergin MT
J Immunol; 1986 Mar; 136(5):1888-92. PubMed ID: 2419418
[TBL] [Abstract][Full Text] [Related]
10. "Hidden" cytotoxic antibodies that react with allogeneic cultured fetal and tumor cells contained in soluble immune complexes from normal human sera.
Morgan AC; Rossen RD; McCormick KJ; Stehlin JS; Giovanella BC
Cancer Res; 1982 Mar; 42(3):881-7. PubMed ID: 7059986
[TBL] [Abstract][Full Text] [Related]
11. [Cytotoxicity of the lymphocytes of melanoma patients against autologous tumor cells and its in vitro enhancement].
Bykovskaia SN; Iobadze MS; Kupriianova TA; Demidov LV
Biull Eksp Biol Med; 1987 Jan; 103(1):86-9. PubMed ID: 2948576
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression.
Mukherji B; Nashed AL; Guha A; Ergin MT
J Immunol; 1986 Mar; 136(5):1893-8. PubMed ID: 2419419
[TBL] [Abstract][Full Text] [Related]
13. Effect of chemotherapy and immunotherapy on tumor-specific immunity in melanoma.
Mitchell MS; Mokyr MB; Davis JM
J Clin Invest; 1977 Jun; 59(6):1017-26. PubMed ID: 863999
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of lymphocytes from healthy subjects and from melanoma patients against cultured melanoma cells.
Pavie-Fischer J; Kourilsky FM; Picard F; Banzet P; Puissant A
Clin Exp Immunol; 1975 Sep; 21(3):430-41. PubMed ID: 1204255
[TBL] [Abstract][Full Text] [Related]
15. The decreased susceptibility of metastatic melanoma cells to killing involves an alteration of CTL reactivity.
Gassara A; Messai Y; Gaudin C; Abouzahr S; Jalil A; Diarra-Mehrpour M; Faure F; Richon C; Avril MF; Even J; Chouaib S
Int J Oncol; 2006 Jul; 29(1):155-61. PubMed ID: 16773195
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of lymphocyte blastogenesis--inhibiting factors in sera of melanoma patients.
Rangel DM; Golub SH; Morton DL
Surgery; 1977 Aug; 82(2):224-32. PubMed ID: 877866
[TBL] [Abstract][Full Text] [Related]
17. [Cytotoxic immunity indices of melanoma B16 growth in mice].
Korosteleva TA; Veresova OV
Vopr Onkol; 1980; 26(1):67-70. PubMed ID: 7355591
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic antibody reactivity in sera of melanoma patients against allogeneic and autologous cultured tumor cells and fibroblasts.
Brown JM; Shoffner PC; Tondreau SP; Matthews EJ; Terry WD; Rosenberg SA
Cancer Res; 1982 Jun; 42(6):2216-22. PubMed ID: 7074602
[No Abstract] [Full Text] [Related]
19. The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.
Guillot B; Portalès P; Thanh AD; Merlet S; Dereure O; Clot J; Corbeau P
Br J Dermatol; 2005 Apr; 152(4):690-6. PubMed ID: 15840100
[TBL] [Abstract][Full Text] [Related]
20. Melanoma and immunity.
Rheins LA; Nordlund JJ
Immunol Ser; 1989; 46():769-87. PubMed ID: 2484957
[No Abstract] [Full Text] [Related]
[Next] [New Search]
